These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17824062)

  • 21. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y; Averbuch M; Schwartz D; Kornovsky R; Levo Y
    Harefuah; 1991 Dec; 121(12):521-4. PubMed ID: 1794760
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlipidemia in the nephrotic syndrome.
    Keane WF; Kasiske BL
    N Engl J Med; 1990 Aug; 323(9):603-4. PubMed ID: 2381446
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM; Vega GL
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of hyperlipidemia in adults with nephrotic syndrome.
    Khanna UB; Nerurkar SV; Almeida AF; Taskar SP; Acharya VN
    J Postgrad Med; 1985 Jul; 31(3):140-5. PubMed ID: 4087215
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine proteins in various renal diseases as studied by gel filtration and paper electrophoresis.
    Kokot F; Kuska J; Koziak H; Zazgórnik J
    Acta Med Pol; 1970; 11(1):15-27. PubMed ID: 5449383
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Gambari PF
    G Clin Med; 1973 Oct; 54(10):714-33. PubMed ID: 4789301
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective.
    Williams ME
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):209-20. PubMed ID: 17699209
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
    Rumpf KW; Quellhrost E; Scheler F
    Med Klin; 1976 Nov; 71(46):2023-7. PubMed ID: 995042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nephrotic hyperlipidemia and its clinical significance].
    Neverov NI; Srinivas KV
    Ter Arkh; 1990; 62(6):150-3. PubMed ID: 2218917
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperglycemic nonketotic coma in insulin-dependent diabetes mellitus.
    Brockman W; Cordova LJ; Davis PJ
    Johns Hopkins Med J; 1970 Aug; 127(2):119-23. PubMed ID: 5471978
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperlipidemia and nephropathy: cause or consequence?].
    Guijarro C; Keane WF
    Med Clin (Barc); 1995 Oct; 105(13):496-7. PubMed ID: 7494438
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hyperlipidemia in human renal disease.
    D'Amico GD; Gentile MG
    Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention and management of complications in nephrotic syndrome].
    Mitarai T
    Nihon Rinsho; 2004 Oct; 62(10):1893-7. PubMed ID: 15500136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary hyperlipemia caused by chronic kidney failure in chronic pyelonephritis in childhood].
    Rabenalt P; Wünsche W; Mank H
    Kinderarztl Prax; 1977 Jun; 45(6):261-6. PubMed ID: 894921
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired hyperlipidemia (secondary dyslipoproteinemias).
    Chait A; Brunzell JD
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):259-78. PubMed ID: 2192873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 40. Nutritional aspects of cardiovascular renal diseases.
    Kark RM; Oyama JH
    Prog Food Nutr Sci; 1975; 1(9):611-44. PubMed ID: 772757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.